| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51b7f64f380c538d4b6aa024f05455da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_661c68977a99ccd5a68ea29d1b870a1b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e96a7912a4e01334aca3ffd3babe863
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D249-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 |
| filingDate |
2015-12-18^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8bb6c24f629349139fe3cc5bd19f328e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d210ea39bf7749ab849e0a21e34e5793
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_610ffa3402165758754aa4ca0415c617 |
| publicationDate |
2016-06-30^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016106105-A1 |
| titleOfInvention |
Amidoethyl azole orexin receptor antagonists |
| abstract |
The present invention is directed to amidoethyl azole compounds which are antagonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10010539-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10011595-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10000499-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10017504-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10150751-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10155750-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10435398-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9920038-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9938276-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10214535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10227336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239838-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987255-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9994570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10526336-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10308645-B2 |
| priorityDate |
2014-12-23^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |